IRMDIRADIMED CORPORATION
$87.53+26% 1Y
$87.53
$67.7752 weeks$104.87
The financials
IRADIMED CORPORATION by the numbers
IRADIMED CORPORATION (IRMD) reported revenue of $20M in Q2 2026 (quarter ended Jun 30, 2026), up 0.3% from the same quarter a year earlier. That came with a gross margin of 74% and net income of $5.2M (25% of revenue). For the full year FY2025, revenue was $84M (+14% year on year) and net income $22M. Its largest region in Q2 2026 was United States at $17M, 82% of the disclosed total, well ahead of Non Us at 18%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $20M | $20M | +0.3% |
| Gross profit | $15M | $16M | −5.0% |
| Operating income | $6.4M | $6.8M | −5.8% |
| Net income | $5.2M | $5.8M | −9.6% |
| Diluted EPS | $0.41 | $0.45 | −8.9% |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $17M | 82% |
| Non Us | $3.7M | 18% |
Business segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $20.5M (-6.9%)
Non Us grew +69% year on yearUnited States -8.1% year on year
Segment Latestquarter on quarteryear on year
- United States$16.7M$16.7Mquarter on quarter -7.2%year on year -8.1%-7.2%-8.1%
- Non Us$3.7M$3.7Mquarter on quarter -5.3%year on year +69%-5.3%+69%